We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Steady Growth Seen for North American Patient Monitoring Industry

By HospiMedica International staff writers
Posted on 21 Aug 2008
Growth of the North American patient monitoring industry is being driven by sleep apnea, diabetes blood glucose monitoring, and information technology (IT) integration. More...
These are the latest finding of Frost and Sullivan (Palo Alto, CA, USA), an international consulting firm.

A rise in the level of acuity amongst patients, coupled with a shortage of nurses, increases the demand for sophisticated patient monitoring solutions in North America. Market participants continue to work toward the integration of IT with their products to ensure a seamless transfer of information between devices and hospital information systems. In particular, the sleep apnea segment holds significant opportunity as one in every five adults in the United States suffers from some form of obstructive sleep apnea (OSA). Industry sources estimate that less than 10% of people suffering from this disease have been diagnosed or treated, thus creating a huge market opportunity for device manufacturers.

Similar opportunities exist in the diabetes glucose monitoring market, as the incidence of diabetes within the United States has increased by about 50% between the years 1998 and 2005. An estimated 54 million people suffered from prediabetes in 2005. Additionally, according to the U.S. national diabetes education program, diabetes could potentially grow at 10% percent a year if left untreated. This large population base creates a continuous demand for blood glucose self-monitoring devices. Furthermore, alternate site testing (thigh and forearm) has lowered the perception of pain, in turn bolstering the development of the market.

"Sleep apnea, hospital wireless, and diabetes blood glucose monitoring are the fastest-growing segments in the North American patient monitoring industry,” said Frost & Sullivan research consultant Sheetal Rajani. "Under-diagnosis of sleep apnea, overcrowded specialty areas, and an increasing prevalence of diabetes are the major factors driving growth in these segments.”

Frost and Sullivan have found that the North American patient monitoring industry earned revenues of US $7.03 billion in 2007 and is expected to demonstrate a continuous annual growth rate (CAGR) of 7.2% between 2007-2012. Additionally, the U.S. government has mandated electronic medical records (EMRs) by 2014. As a result, there is a growing need to integrate IT with patient monitoring systems to ensure a seamless transfer of information. In order to facilitate a smooth interface, patient-monitoring companies must ensure that their devices are compatible with the hospital's information system.

Related LInks:
Frost and Sullivan


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.